ImmunologybioRxivPreprint
De novo administration of antiviral monoclonal antibodies against SARS-CoV-2 or influenza using mRNA lipid nanoparticles
Mai N. Vu, Jessica Anne Neil, Charley Mackenzie-Kludas…·Adam K. Wheatley
This study compares traditional mAb infusion with mRNA/LNP-based de novo mAb expression in mice, finding high serum concentrations but compromised protective capacity due to anti-drug antibodies.